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Introduction: The golden standard in the management of systemic lupus erythematosus (SLE) 
is the hydroxycloroquine. The main listed side effects of hydroxycloroquine are the ocular toxicity and 
in lupus with myositis overlaps the desquamation. 
Clinical case: A female patient known with a history of sterility and upper respiratory tract 
infection (started on June 2015 and resolved in December 2015) on treatment with Amoxicillin and 
symptomatics presents in January 2016 with parotid swelling and sicca symptoms. Corroborating the 
history (photosensibility, amoxicillin intake, parotid swelling, sicca symptoms, mother diagnosed with 
psoriasis) with the immunology panel (positive antibodies for SSA, SSB, RO-52, dsDNA and histone) 
the patient was diagnosed with secondary Sjogren Syndrome Associated with drug induced SLE. 
Hydroxicloroquine Associated with low doses of Prednisone was started. After the first dose, the patient 
complained about pruritus and extended erythematosus plaque. She was admitted in the ER. She was 
put on high doses of corticosteroids and the hydroxycloroquine was stopped. A skin biopsy was 
performed showing a pattern characteristic for toxic dermatitis. Results from a prior parotid biopsy are 
expected. The patient was admitted in the Department of Rheumatology to start a new drug treatment.
Conclusion: Four major questions arised from the history of our patient. Did we missed 
something prior the onset of the treatment with hydroxycloroquine? Was the Amoxicillin to be blamed 
for the drug induced lupus? Are we dealing with a secondary Sjogren syndrome with complications –
eg. lymphoma? What is the best treatment to be started? 
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Introduction: Multifocal motor neuropathy with conduction block (MMN-BC) is a rare disease 
and a distinct entity, its clinical and electrophysiological features differ from other chronic inflammatory 
demyelinating neuropathies. Its’ first description in 1988 lead to new diagnosing assessments. The 
distinction of this disease is very important as the treatment differs and incorrect treatment can lead to 
clinical decline.
Clinical case: We report a case of a 62-year old man who developed muscular weakness in all 
his four limbs, muscle wasting of both hands (2005), claudication, difficulty ascending stairs, muscular 
